Inquiry Basket
Loading ......
Filter By Product Search for
RSPO1
RSPO1 Full Name
R-spondin 1
RSPO1 Introduction
R-Spondin 1 (RSPO1) is a secreted protein that has emerged as an important regulator of stem cell maintenance, tissue regeneration, and developmental signaling. Many researchers studying organoids, regenerative medicine, and disease modeling face a common challenge: maintaining long-term stem cell activity while preserving the biological characteristics of native tissues. RSPO1 has attracted significant attention because it functions as a potent enhancer of the canonical Wnt/β-catenin signaling pathway, primarily through interaction with leucine-rich repeat-containing G protein-coupled receptors (LGR4, LGR5, and LGR6). By strengthening Wnt signaling activity, RSPO1 promotes the expansion and survival of adult stem cells, especially LGR5-positive intestinal stem cells, which are essential for epithelial renewal. Studies in intestinal organoid systems have demonstrated that recombinant human RSPO1 can significantly increase organoid growth, improve cell survival, and enhance tissue formation efficiency by increasing active non-phosphorylated β-catenin levels and maintaining the intestinal stem cell niche. These properties make RSPO1 a widely used growth factor component in organoid culture systems and a valuable tool for studying tissue regeneration mechanisms.
Beyond intestinal regeneration, RSPO1 plays diverse roles in development, immune regulation, and cellular homeostasis through modulation of multiple Wnt-associated pathways. During embryonic development, RSPO1 contributes to tissue patterning and morphogenesis by influencing both canonical and non-canonical Wnt signaling networks. Research in zebrafish models has shown that abnormal RSPO1 expression can disrupt convergent extension movements during early embryogenesis, highlighting its role in controlling developmental processes through regulation of Wnt/PCP signaling. In the central nervous system, RSPO1 has also been linked to inflammatory regulation. Recent studies using human induced pluripotent stem cell-derived cortical astrocytes found that RSPO1 can alter cytokine production profiles by interacting with LGR6 receptors, affecting pathways associated with cytokine-receptor interactions, chemokine signaling, and TNF signaling. These findings suggest that RSPO1 may participate in maintaining cellular balance within neural tissues and may provide new opportunities for investigating neuroinflammation and neurodegenerative disease mechanisms.
Due to its strong influence on stem cell activity and tissue microenvironment regulation, RSPO1 has become increasingly relevant in disease research, regenerative therapies, and advanced in vitro models. Dysregulation of RSPO1-related signaling has been associated with abnormal tissue growth, developmental disorders, and cancer biology because excessive activation of Wnt pathways can influence cell proliferation and tumor progression. RSPO1 is also being investigated in cancer organoid platforms, although its effects can vary depending on tumor type and molecular background. For example, while RSPO1 supports the expansion of normal intestinal organoids, studies in certain cancer-derived organoids, such as esophageal squamous cell carcinoma models, indicate that RSPO1 supplementation may not always enhance tumor organoid growth, emphasizing the importance of disease-specific pathway analysis. As research continues, RSPO1 remains a valuable target for understanding stem cell regulation, improving organoid-based drug screening, developing regenerative medicine strategies, and exploring new therapeutic approaches for diseases involving Wnt signaling imbalance. Its ability to regulate cell survival, differentiation, and tissue repair makes RSPO1 an important biological target for both basic research and translational applications.
Alternate Names for RSPO1
RSPO1; R-spondin 1; RSPO; CRISTIN3; R-spondin-1; R-spondin homolog; roof plate-specific spondin-1; anti-RSPO1
Loading ......
